← Browse by Condition
Medical Condition

tardive dyskinesia td

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06731868 Phase 1, Phase 2
Recruiting

Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia

Enrollment
120 pts
Location
China
Sponsor
Luye Pharma Group Ltd.
View Trial →